Panacea Biotec announces launch of ViLACT for type 2 diabetes mellitus patients
It is a new oral anti-diabetic agent that enhances pancreatic islet cell responsiveness to glucose
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.